How can we help you?
Join us for this webinar where our experts will discuss different approaches for developing rigorous economic model structures for rare diseases.
We'll help you navigate and understand the emerging ISPOR/ISPE Real World Evidence guidelines.
This webinar, based on PRO labeling of cancer treatment drugs, will examine Trends in EMA and FDA labeling based on patient-reported outcomes (PROs).
Watch this introductory presentation as our experts walk through an overview of this approach used to help asses relative differences in treatments.
For this advanced session on network meta-analysis, listen as our panel of experts discusses some of the recent developments in Bayesian NMA.
In this webinar, we will share design strategies for avoiding selection bias and improving efficiency in observational studies.